High-impact quantitative meta-analysis adhering strictly to PRISMA and Cochrane guidelines—delivering pooled effect sizes, forest plots, heterogeneity testing, and meta-regression.
In evidence-based medicine, social sciences, and clinical psychology, a well-executed systematic review and meta-analysis sits at the very apex of the evidence hierarchy. Papers with meta-analyses consistently receive higher citation rates and faster editorial acceptance in high-impact journals.
At IJRDO, our meta-analysis biostatisticians guide you through the complete quantitative synthesis. From converting heterogeneous outcome metrics into standardized effect sizes to generating publication-ready forest plots and testing for publication bias, we ensure your meta-analysis withstands the most rigorous peer review.
Structured adherence to internationally recognized systematic review and quantitative synthesis protocols.
Modeling executed in R (meta, metafor packages), RevMan (Review Manager), Comprehensive Meta-Analysis (CMA), or STATA.
Integration with RoB 2, ROBINS-I, Newcastle-Ottawa Scale (NOS), and GRADE evidence certainty ratings.
Validating robustness of pooled findings by systematically excluding single outlier trials.
Every project includes complete PRISMA 2020 flow diagrams, study characteristics summary tables, risk of bias summary graphs, and comprehensive subgroup sensitivity analyses.
Have a preliminary study extraction table and want to verify statistical feasibility? Send your records for an effect-size appraisal.
Consult Meta-Analysis Statistician →